A costing study of bortezomib shows equivalence of its real-world costs to conventional treatment
General Info
Time period covered
January, 2002 - December, 2012
Data type
Scientific literature
Keywords
Citation
Journal
Br J Haematol
Pages
e76-e79
Publication year
2020
Suggested citation
Thompson JF, Teh Z, Chen Y, Gardiner J, Bednarz JM, Thompson GN, Lee C, Horvath N, Bardy P, Yeung D. A costing study of bortezomib shows equivalence of its real-world costs to conventional treatment. Br J Haematol. 2020; 189(3): e76-e79.